BONESUPPORT commenced direct U.S. sales of bone void filler CERAMENT® BVF.
The company announced its direct sales initiative earlier this year. The plan is to expand product offerings in the region and raise brand awareness ahead of launch of CERAMENT G antibiotic eluting product.
BONESUPPORT‘s U.S. network comprises 25 distributors employing 512 sales reps. The company also has sales agreements with Collagen Matrix and MTF Biologics that are complementary to CERAMENT BVF, which will take hold in 2019.
BONESUPPORT commenced direct U.S. sales of bone void filler CERAMENT® BVF.
The company announced its direct sales initiative earlier this year. The plan is to expand product offerings in the region and raise brand awareness ahead of launch of CERAMENT G antibiotic eluting product.
BONESUPPORT‘s U.S. network comprises 25 distributors...
BONESUPPORT commenced direct U.S. sales of bone void filler CERAMENT® BVF.
The company announced its direct sales initiative earlier this year. The plan is to expand product offerings in the region and raise brand awareness ahead of launch of CERAMENT G antibiotic eluting product.
BONESUPPORT‘s U.S. network comprises 25 distributors employing 512 sales reps. The company also has sales agreements with Collagen Matrix and MTF Biologics that are complementary to CERAMENT BVF, which will take hold in 2019.
Copy to clipboard 
